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Despite the introduction of safe, effective vaccines 
decades ago and joint global public health efforts 
to eliminate measles, this vaccine-preventable dis-
ease continues to pose threats to children’s health 
worldwide. During 2013 and 2014, measles virus was 
introduced into Denmark through several independ-
ent importations. This resulted in a number of second-
ary cases (n = 7), with two clusters in 2013 and one in 
2014. In total, there were 44 cases of measles. Most 
cases (n = 41) were laboratory confirmed by detection 
of measles virus genome by real-time reverse tran-
scription (RT)-PCR and IgM antibodies. The viruses 
from confirmed cases were genotyped by sequencing. 
Only one genotype circulated each year, i.e. D8 and 
B3, respectively. Sequencing of measles virus from 
different clinical specimens from the same patients 
revealed that sequence variants of measles viruses 
might co-exist and co-transmit during an outbreak. 
The majority of the cases were unvaccinated (n = 27) 
or recipients of one dose of measles-mumps-rubella 
(MMR) vaccine (n = 7). In addition, two fully vaccinated 
adult cases were reported in 2014. We demonstrate 
the transmission of measles virus in a population in 
which the two-dose MMR vaccination coverage rate 
was 80% and how even vaccinated individuals may be 
at risk of contracting measles once transmission has 
been established.
Introduction
Measles is caused by a negative-sense single-stranded 
RNA virus belonging to the Morbillivirus genus. The 
wild-type measles virus consists of 24 genotypes that 
are grouped into eight clades [1]. Measles is one of 
the leading causes of childhood mortality worldwide: 
about 145,700 people died from measles in 2013, most 
of them children under the age of five years [2].
The first measles-mumps-rubella (MMR) vaccination 
programme was implemented in the 1960s in the United 
States [3]. The World Health Organization (WHO) has 
set the goal of eliminating measles in Europe by 2015 
and globally by 2020 [4]. In 2013, the WHO Regional 
Office for Europe produced a supplement for acceler-
ated action during 2013 to 2015 [5]. In this supplement, 
WHO identified a number of acceleration strategies to 
achieve this goal by the end of 2015: (i) immunisation 
system strengthening; (ii) establishing and improv-
ing case-based surveillance; (iii) improving labora-
tory and epidemiological data integration; and (iv) 
improving outbreak response. These strategies have 
been adapted and are some of the key elements in the 
Danish national disease elimination efforts.
In Denmark, measles is a notifiable disease, and 
national measles surveillance is conducted through 
close collaboration between the WHO National 
Reference Laboratory for Measles and Rubella at 
the Department of Microbiological Diagnostics and 
Virology at the Statens Serum Institut (SSI), the 
Department of Infectious Disease Epidemiology, SSI, 
the Danish Health and Medicines Authority, general 
practitioners (GPs), hospital clinicians, regional hospi-
tal microbiology laboratories and public health medi-
cal officers. The public health medical officers perform 
contact tracing and give advice to hospitals and GPs on 
post-exposure prophylactic therapeutics.
In Denmark, the first dose of MMR vaccine has been 
given at the age of 15 months since its introduction in 
1987. In 2008, the Danish Expanded Programme on 
Immunisation (EPI) schedule was changed and the tim-
ing of the second MMR vaccine dose adjusted from 12 
years to 4 years of age. The rationale for the change 
was to increase herd immunity by increasing the immu-
nity of children aged under 12 years [6].
Since 1996, MMR vaccination status in Denmark has 
been recorded in a national vaccination database, in 
which data are automatically entered when GPs use 
specific codes for reimbursement for performing the 
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vaccinations. Since the introduction of this database, 
MMR vaccination coverage in Denmark has been esti-
mated to be 88–90% for the first dose and 83–88% 
for the second [7]. That is until 2013, when coverage 
decreased to 87% for the first dose and 80% for the 
second, underlining the challenge facing the Danish 
EPI programme when trying to meet the goal of 95% 
coverage, as recommended by WHO [8]. However, a 
study in which parents of children not registered in the 
national database were interviewed about the vaccina-
tion status of their children documented under-report-
ing of coverage in the database, to the magnitude of 
3–4 percentage points [7]. Given this, and the fact that 
the vaccination of some of children will be delayed [7], 
coverage may be higher in reality. 
The advantage of molecular characterisation of mea-
sles virus followed by phylogenetic analysis during 
outbreaks has been demonstrated previously [9,10]. In 
our current study, we combine phylogenetic analyses 
of viruses from confirmed measles cases in Denmark 
during 2013 and 2014 with classical epidemiological 
investigations in order to investigate the consequences 
of imported cases of measles and the associated 
potential public health challenges in the attempt to 
keep a nation free of endemic transmission of measles 
virus.
Methods
We used the European Union measles case defini-
tion, as described by ECDC [11]. We defined a cluster 
as having a minimum of three persons with measles, 
for whom an epidemiological link to an identified index 
case, either directly or by secondary infection, was 
established.
For any measles case, the local GP takes the lead on 
collecting all available information on the patient 
that is necessary for public health action, such as the 
likely source of exposure and contacts of the case. 
This information is recorded in a standardised noti-
fication Form (National Board of Health form 1515), 
which is sent to both the Department of Infectious 
Disease Epidemiology at SSI and to the Regional State 
Epidemiologist (RSE). After receiving the official notifi-
cation form, the RSE decides on the appropriate public 
health action, e.g. tracing unvaccinated contacts and 
the extent of administration of prophylactic vaccina-
tion or immunoglobulin. 
Figure 1
New measles notifications by week in Denmark, 2013 and 2014 (n = 44)
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For the 41 laboratory-confirmed cases (shown in blue), the notification date is based on first sampling day. For the three probable cases, 
whose infection was not laboratory confirmed but diagnosed based on clinical criteria and epidemiological link (shown in green), GP 
diagnosis date is used.
For 2014, only weeks 1–37 are shown, but no cases were notified during the rest of the year.
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Analysis of specimens
During 2013 to 2014, specimens from suspected mea-
sles cases – primarily urine, throat swabs and serum – 
were sent to the WHO National Reference Laboratory for 
Measles and Rubella, SSI, for laboratory confirmation 
and further characterisation of measles virus-positive 
samples. In most cases, multiple specimens were sub-
mitted simultaneously. Serum specimens were tested 
for IgG and IgM antibodies using a BEP 2000 Advance 
system (Siemens Healthcare) with an in-house ELISA 
(unpublished data). Measles virus RNA was purified 
using the MagNA pure LC system (Roche), using the 
Total NA kit (Roche). 
All samples (serum, throat swabs and urine) were fur-
ther tested for the presence of measles virus RNA by 
real-time reverse transcription-PCR (RT-PCR) accord-
ing to the procedures described by Mubarak et al. [12]. 
Positive samples were further characterised by RT-PCR 
followed by Sanger sequencing on an ABI 3100 (Thermo 
Fischer) using primers and running conditions as rec-
ommended by WHO [13]. Measles virus sequences were 
genotyped online using the 450 bp fragment of the N 
gene recommended for genotyping by WHO by the 
shared member state sequence database, the Measles 
Nucleotide Surveillance (MeaNS) tool [14]. 
Phylogenetic analyses were performed by alignment 
and neighbour-joining tree-building using ClustalW 
[15]. Bootstrapping was performed using 1,000 repli-
cates. Sequences shorter than the recommended 450 
bp were excluded from the phylogenetic analysis.
Vaccination status
Vaccination status was based on data available in the 
national vaccination database, which was initiated 
in 1996; status before this was based on statements 
from the patient and/or the GP. Thus, vaccination sta-
tus was only fully available in the database for persons 
up to 17 years and 18 years of age, in 2013 and 2014, 
respectively.
Nomenclature
Confirmed cases were recorded using the year and 
chronological order in which they were laboratory con-
firmed (e.g. the first case in 2013 was given the ID 2013-
01). All viral sequences were named in accordance with 
the WHO standards implemented by MeaNS [14].
Figure 2
Possible transmission routes in clusters of measles cases in Denmark, 2013 and 2014 (n = 17)
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For 2013, only the large cluster is shown. Solid lines show epidemiological links involving known close contact with a measles case, whereas 
dotted lines indicate possible contact. The arrows show the direction of transmission. Double-headed arrows indicate a possible connection 
between the cases but the direction of the transmission cannot be established.
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Results
Epidemiology of measles cases in Denmark in 
2013 and 2014
In 2013 and 2014, 17 and 27 measles cases were noti-
fied, respectively. In 2013, all cases were laboratory 
confirmed, whereas in 2014, 24 cases were labora-
tory confirmed, while GPs (one in France and two in 
Denmark) diagnosed the remaining three probable 
cases, based on clinical and epidemiological criteria.
In 2013, the cases were notified during weeks 3 to 12, 
whereas in 2014, the first notification came slightly 
later, but the cases were notified over a longer period 
(weeks 7–34) (Figure 1). In the latter cases, diagnosis 
was based on clinical signs and epidemiological links 
to known laboratory confirmed cases. For a detailed 
overview of all cases from both years, see the Table.
In 2013, there was a large cluster consisting of nine epi-
demiologically linked cases (case ID 2013-04 to 2013-
09, 2013-11, 2013-12 and 2013-14) and a small cluster 
of four cases (2013-13 and 2013-15 to 2013-17). An addi-
tional four unlinked cases were detected: three of 
these cases (2013-01 to 2013-03) were notified before 
the first cluster was identified. One had travelled from 
the United Kingdom and one from Asia during the incu-
bation period; the source of the infection of the third 
was unknown. The only other unlinked case (2013-10), 
occurred during the same time as the cases in the large 
cluster and was of the same age group as the majority 
in the cluster (7–11 years), but no epidemiological link 
could be established. 
During 2014, a single cluster was detected, consisting 
of eight cases (2014-01 to 2014-04, 2014-06, 2014-08, 
2014-10 and 2014-16). In addition, five imported cases 
each resulted in one secondary case (2014-05 linked to 
2014-07, 2014-09 linked to 2014-11, 2014-12 linked to 
2014-14, 2014-15 linked to 2014-20, and 2014-19 linked 
to 2014-22) and one importation (2014-24) resulted 
in two secondary cases (2014-25 and 2014-27). The 
remaining six cases were regarded as individual impor-
tations for whom no epidemiological links could be 
established. The cases for whom the travel history was 
known showed travel to Asia (2014-05 and 2014-12), 
the Netherlands and Germany (2014-13) and Turkey 
(2014-24). One case, an asylum seeker (2014-26), had 
been travelling through Europe, but the sequence of 
the measles virus from that case grouped together 
with that from the case who had travelled to Turkey 
(see below).
In 2013, the first measles case was identified in mid-
January as an imported case from the United Kingdom. 
Within two weeks, two other unconnected cases were 
confirmed, one imported from Asia and one with no 
travel history. The index case of the 2013 large cluster 
was diagnosed with measles during the first week of 
March. The patient (2013-04), aged 10–19 years, had 
returned to School A after a trip to Asia. In the same 
school, four other pupils were also diagnosed with 
measles within the incubation period for the disease. 
Two weeks after the introduction of measles at School 
A, a child at another school (School B), comprising 
pupils of the same age group, located less than 200 
metres from School A, was diagnosed with measles 
and two weeks later, another child was diagnosed with 
measles at School B. In addition to the seven pupils 
from the two schools, this cluster also contained two 
individuals with a possible epidemiological link to the 
cluster: a person in their 30s who used the car park at 
School A and a person in their 40s who lived close to 
both schools (Figure 2). 
The second smaller measles cluster occurred in a day-
care centre, in the same town as the larger cluster, 
involving three children aged under 4 years and a per-
son in their 20s (Table). Even though direct epidemio-
logical links between this and the large cluster could 
not be established, sequence homology of the measles 
viruses and the close proximity in time and location 
suggest a link between the two clusters. The remain-
ing case from 2013 (2013-10), even though no epide-
miological link could be established, were connected 
to the same town; thus 14 of the 17 cases in 2013 were 
relatively closely linked geographically.
The index case of the 2014 cluster (2014-01) was 
an unvaccinated child aged under four years with no 
known travel history outside Denmark. Before being 
Figure 3
Measles cases by age group, Demark, 2013 and 2014 (n = 
44)
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MMR: measles-mumps-rubella; NK: unknown; PEP: post-exposure 
prophylaxis; RT-PCR: real-time reverse transcription-PCR.
Vaccination status: − indicates that the person was not vaccinated 
with a measles virus-containing vaccine; + indicates that the 
person had received the first dose of MMR vaccine; + + indicates 
that the person had received both doses of MMR vaccine.
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Figure 4
Neighbour-joining tree showing the phylogenetic relationship of measles virus sequences from cases in Denmark, 2013 and 
2014
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D8 MVi/MANCHESTER.GBR/30.94/
D8 MVs/TAUNTON.GBR/27.12/
D8 MVs/SWANSEA.GBR/4.13/
MVs/Silkeborg.DNK/14.13/  2013-10 urine 
MVs/Silkeborg.DNK/12.13/5  2013-09 swab 
MVs/Silkeborg.DNK/12.13/4  2013-08 other 
MVs/Silkeborg.DNK/12.13/3  2013-07 other 
MVs/Silkeborg.DNK/13.13/  2013-07 urine 
MVs/Silkeborg.DNK/15.13/  2013-12 swab 
MVs/Silkeborg.DNK/12.13/2  2013-06 serum 
MVs/Silkeborg.DNK/16.13/  2013-13 urine 
MVs/Silkeborg.DNK/15.13/2  2013-13 swab 
MVs/Silkeborg.DNK/16.13/2  2013-14 swab 
MVs/Silkeborg.DNK/12.13/  2013-05 swab 
MVs/Silkeborg.DNK/10.13/  2013-04 swab 
MVs/Kobenhavn.DNK/5.13/2  2013-02 swab 
MVs/Kobenhavn.DNK/5.13/  2013-02 urine 
D8 MVi/VILLUPURAM.IND/03.07/
D8 MVs/FRANKFURT MAIN.DEU/17.11/
MVs/Aarhus.DNK/5.13/  2013-03 urine 
MVs/Aarhus.DNK/5.13/2  2013-03 swab 
B3 MVi/NEW YORK.USA/0.94/
B3 MVs/LIVERPOOL.GBR/5.12/
B3 MVi/IBANDAN.NGA/0.97/
B3 MVs/NOTTINGHAM.GBR/50.05/
B3 MVs/ALLADA.BEN/3.10/
MVs/Aarhus.DNK/16.14/  2014-13 serum 
MVs/Aarhus.DNK/15.14/  2014-13 swab 
B3 MVs/Bad Segeberg.DEU/13.14/
B3 MVs/TONBRIDGE.GBR/5.14/
MVs/Herlev.DNK/14.14/  2014-11 swab 
MVs/Stenlose.DNK/10.14/2  2014-05 swab 
MVs/Frederiksberg Kommune.DNK/9.14/2  2014-03 swab 
MVs/Hvidovre.DNK/10.14/2  2014-04 urine 
MVs/Frederiksberg Kommune.DNK/9.14/3  2014-03 urine  
MVs/Hvidovre.DNK/10.14/  2014-04 swab 
MVs/Kobenhavn.DNK/9.14/3  2014-02 urine 
MVs/Kobenhavn.DNK/7.14/  2014-01 serum 
MVs/Kobenhavn.DNK/16.14/2  2014-16 urine 
MVs/Kobenhavn.DNK/16.14/  2014-15 urine 
MVs/Kobenhavn.DNK/9.14/  2014-02 serum 
MVs/Kobenhavn.DNK/9.14/2  2014-02 swab 
MVs/Herlev.DNK/12.14/2  2014-09 swab 
MVs/Stenlose.DNK/11.14/  2014-07 other 
MVs/Kobenhavn.DNK/16.14/3  2014-16 swab 
MVs/Kobenhavn.DNK/16.14/5  2014-18 serum 
MVs/Frederikshavn.DNK/19.14/  2014-21 swab 
MVs/Hjorring.DNK/19.14/  2014-22 swab 
MVs/Frederikshavn.DNK/18.14/  2014-19 swab 
MVs/Bronshoj.DNK/23.14/2  2014-23 swab 
MVs/Kobenhavn.DNK/14.14/  2014-12 other 
MVs/Kobenhavn.DNK/11.14/  2014-06 swab 
MVs/Stenlose.DNK/10.14/  2014-05 urine 
MVs/Kobenhavn.DNK/7.14/3  2014-01 swab 
MVs/Kobenhavn.DNK/7.14/2  2014-01 urine 
MVs/Kobenhavn.DNK/15.14/  2014-12 serum 
B3 MVi/HARARE.ZWE/38.09/
MVs/Bronshoj.DNK/23.14/  2014-23 urine 
MVs/Kobenhavn.DNK/16.14/4  2014-17 urine 
MVs/Kobenhavn.DNK/15.14/2  2014-12 urine 
MVs/Herlev.DNK/12.14/  2014-09 urine 
MVs/Hvidovre.DNK/13.14/  2014-10 swab 
MVs/Frederiksberg Kommune.DNK/9.14/  2014-03 serum 
MVs/Albertslund.DNK/32.14/  2014-24 urine 
MVs/Albertslund.DNK/32.14/2  2014-24 other 
MVs/Albertslund.DNK/34.14/  2014-25 urine 
MVs/Albertslund.DNK/34.14/2  2014-25 swab 
MVs/Albertslund.DNK/34.14/3  2014-25 other 
MVs/Ronne.DNK/33.14/  2014-26 swab 
MVs/Kobenhavn.DNK/34.14/  2014-27 other 
Only sequences consisting of the recommended 450 bp of the measles virus N region were included in the analysis (57 sequences from 36 
cases). Bootstrapping was performed using 1,000 replicates (for clarity, bootstrap values are omitted). The names of the sequences consist 
of the name assigned by MeaNS followed by the case ID and the type of specimen. Reference strains show the genotype followed by the 
name of the reference strain in capital letters.
The chromatograms showing the conserved single base mutation between the two B3 clades is included to show the unambiguity of the 
sequencing results.
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Case ID
Age 
group 
in years
RT-PCR-positive sample
Vaccination 
status
First 
sampling 
dateb
Epidemiological link
Serum Urine
Throat 
swab Unknowna
2013-01 20–29 − 17 Jan 2013 Travel to United Kingdom
2013-02 30–39  + 31 Jan 2013 Travel to Asia
2013-03 20–29 − 1 Feb 2013 Unknown
2013-04 10–19  + 8 Mar 2013 Index case of large cluster (stay in Asia)
2013-05 10–19  + 18 Mar 2013 2013-04 ( attended School A)
2013-06 10–19 − 19 Mar 2013 2013-04 (attended School A)
2013-07 40–49 − 21 Mar 2013 Lived close to Schools A and B
2013-08 5–9 − 21 Mar 2013 2013-04 (attended School A)
2013-09 5–9  + 22 Mar 2013 2013-04 (attended School A)
2013-10 5–9 − 2 Apr 2013 Unknown
2013-11 10–19  + 2 Apr 2013 Classmate of 2013-14 at School B
2013-12 30–39 Unknown 8 Apr 2013 Used car park at School A
2013-13 0–4 − 14 Apr 2013 Index case of small cluster (source of infection unknown)
2013-14 10–19 − 18 Apr 2013 Classmate of 2013-11 at School B
2013-15 0–4 − 19 Apr 2013 2013-13 (attended Day-care centre A)
2013-16 0–4 − 20 Apr 2013 2013-13 (attended Day-care centre A)
2013-17 20–29 Unknown 22 Apr 2013 Worked at Day-care centre A
2014-01 0–4 − 12 Feb 2014 Index case of single cluster (source  of infection unknown)
2014-02 0–4 − 25 Feb 2014 2014-01 (in hospital waiting room when 2014-01 present)
2014-03 0–4 − 28 Feb 2014 2014-01 (in hospital waiting room when 2014-01 present)
2014-04 0–4 − 4 Mar 2014 2014-01 (in hospital waiting room when 2014-01 present)
2014-05 30–39  + 5 Mar 2014 Travel to Asia with 2014-07
2014-06 0–4 PEP 10 Mar 2014 2014-02 (family member)
2014-07 30–39  + 10 Mar 2014 Travel to Asia with 2014-05
2014-08 0–4 Not sampled − 14 Mar 2014b 2104-03, attended same day-care centre as 2104-03. Diagnosed in France.
2014-09 20–29 − 20 Mar 2014 Unknown source of infection
2014-10 20–29  + + 26 Mar 2014 2014-04 (family member)
2014-11 30–39  + + 1 Apr 2014 2014–09 (family member)
2014-12 40–49 Unknown 5 Apr 2014 Travel to Asia
2014-13 20–29 − 12 Apr 2014 Travel to Netherlands and Germany
2014-14 0–4 Not sampled − 16 Apr 2014b 2014-12 (relative)
2014-15 30–39 − 20 Apr 2014 Unknown source of infection
2014-16 30–39 − 18 Apr 2014 Lived near 2014-02 and 2014-06
2014-17 20–29 − 16 Apr 2014 Unknown source of infection
2014-18 10–19 − 17 Apr 2014 Unknown source of infection
2014-19 20–29 − 28 Apr 2014 Unknown source of infection
2014-20 1–5 Not sampled − 5 May 2014b 2014-15 (family member)
2014-21 30–39 Unknown 9 May 2014 Unknown source of infection
2014-22 30–39 − 9 May 2014 Worked at hospital where 2014-19 was hospitalised
2014-23 0–4 − 3 Jun 2014 Unknown source of infection
2014-24 30–39 Unknown 4 Aug 2014 Travel to Turkey
2014-25 30–39 Unknown 19 Aug 2014 2014-24 (family member)
2014-26 0–4 Unknown 16 Aug 2014 Sought asylum in Denmark
2014-27 40–49 Unknown 20 Aug 2014 2014-24 (visited 2014-24 in hospital)
Table
Overview of all cases of measles in Denmark, 2013 and 2014 (n = 44)
MMR: measles-mumps-rubella; PEP: post-exposure prophylaxis; RT-PCR: real-time reverse transcription-PCR.
Green cells in the column ‘RT-PCR-positive sample‘ indicate a positive diagnostic real-time RT-PCR from the specimen specified. The grey cells 
in this column indicate that the particular sample type was not submitted.
Vaccination status: − indicates that the person was not vaccinated with a measles virus-containing vaccine; + indicates that the person had 
received the first dose of MMR vaccine; + + indicates that the person had received both doses of MMR vaccine. 
The colour coding in the column ‘Epidemiological link’ indicates the possible links.
a Type of specimen unknown (not specified or information unobtainable for other reasons). 
b Or date of diagnosis for probable cases, based on clinical signs and epidemiological link.
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admitted to the paediatric ward of a hospital, the 
child had stayed in two different waiting rooms: first 
at the GP’s practice and subsequently at the hospital. 
The public health medical officer later determined via 
contact tracing that about 60 children had been in the 
same waiting rooms at some point during the presence 
of the infected child. Information about post-exposure 
prophylaxis to non-vaccinated contacts was sent out 
by post by the public health medical officer, but for 
some contacts, the information was received too late 
to prevent infection (e.g. more than 3–6 days post 
exposure). Subsequently, three (2014-02 to 2014-04) of 
the 60 children (attack rate: 5%), were diagnosed with 
measles, which was confirmed both serologically and 
by RT-PCR. Two of the cases infected in the hospital 
waiting room transmitted the virus to family members, 
one of whom was in their 20s. Moreover, before being 
diagnosed with measles, one of the children who had 
been in the waiting room attended a day-care centre, 
where at least one other child was infected. All but one 
of these cases were aged under 4 years. Additionally, 
a person in their 30s (2014-16) living less than 1,000 
metres from cases 2014-02 and 2014-06 was consid-
ered part of this cluster due to geographical proximity, 
giving a total of eight cases in this cluster. 
Three of the four later cases in 2014 (2014-24, 2014-25 
and 2014-27) were likely connected, in which 2014-25, 
a member of 2014-24’s family, as well as an acquaint-
ance (2014-27) were infected, likely while visiting 2014-
24 during their hospital admission for measles.
Age distribution and vaccination status
The age groups affected differed markedly between the 
two years. In 2013, the majority of the measles cases 
(11/17) were younger than 12 years (Figure 3), whereas 
the majority of cases (16/27) in 2014 were older than 
19 years. 
Most of the 2013 and 2014 cases were unvaccinated 
(10/17 and 17/27, respectively). In Denmark, the two-
dose MMR vaccination programme was implemented 
in 1987. Thus, vaccination can be expected only in 
individuals from 15 months to 27 years of age. In this 
study, 13 of the 27 unvaccinated cases were outside 
this age group. 
In seven cases, only administration of the first dose 
of MMR vaccine could be documented (n = 5 and n = 2 
in 2013 and 2014, respectively). In 2014, two persons 
(2014-10 and 2014-11, in their 20s and 30s, respec-
tively) were infected in spite of having followed the full 
vaccination programme (Figure 3). In both cases, mea-
sles was diagnosed based on clinical symptoms and 
virus detection by RT-PCR from throat swabs. In neither 
of these cases could antibody levels or IgG avidity be 
tested since serum was not submitted.
For the remaining cases in both years, no vaccination 
history could be identified in the records of the national 
vaccination database and/or of the GP (n = 2 and n = 6, 
respectively) (Figure 3).
In 2014, a child aged under four years (2014-06, rela-
tive of 2014–02) received post-exposure vaccination, 
but became symptomatic two weeks after the initial 
symptoms of 2014-02. 
Genotyping and phylogenetic analysis
In 2013, the only measles virus genotype identified was 
D8. Phylogenetic analysis showed that all sequences 
analysed (16 from 12 cases), except for two from the 
same patient (2013-03), were 100% identical to the D8 
reference strain MVi/Villupuram.IND/03.07/. The two 
virus sequences from 2013-03 (from urine and swab 
samples) matched 100% to the D8 reference strain 
MVs/Frankfurt Main.DEU/17.11 (Figure 4). 
In 2014, again only a single genotype was found: B3 (41 
sequences from 24 cases). The majority of sequences 
(23/41) grouped with the B3 reference strain MVi/
Harare.ZWE/38.09/, showing 100% sequence iden-
tity. Another cluster contained nine 100% identical 
sequences from seven cases (Figure 4). The sequences 
in this cluster differed from the Harare strain by only 
a single conserved point mutation (Figure 4). In five 
cases (2014-01, 2014-02, 2014-03, 2014-05 and 2014-
16), the sequence variants were observed in different 
specimens collected from the same patient, indicat-
ing that virus representing both sequences was trans-
ferred simultaneously. In all cases, only one of the two 
variants was detected in individual specimens (Figure 
4). Analysis revealed that this is a silent mutation, not 
altering the amino acid sequence.
One sequence (from case 2014-13) clustered at some 
distance from all known B3 strains. This case was 
a person in their 30s who had travelled from the 
Netherlands via Germany to Denmark and became 
symptomatic after arriving home. The viral sequences 
from this case matched 100% with a sequence found in 
the MeaNS database from a measles case in Germany 
in 2014 (Bad Segeberg/DEU/13.14, GenBank accession 
number: KJ769091). 
Another interesting observation is that the last four 
cases in 2014 (weeks 32–34, 4–20 August) grouped 
together. Case 2014-24 is thought to have imported 
measles from Turkey and probably infected two second-
ary cases (2014-25 and 2014-27). The last case in this 
sequence group was a child seeking asylum in Denmark 
after travelling through Europe. The sequences in this 
group also differ from the B3 MVi/Harare.ZWE/38.09/
reference strain by a single silent base mutation.
Discussion
In 2012, there were two measles cases reported in 
Denmark [16], whereas in 2013 and 2014, 17 and 27 
measles cases were notified, respectively. In these 
two years, only a single genotype was detected: D8 
and B3, respectively, which corresponds well with the 
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genotypes dominating in Europe during these years 
[17,18].
The pattern of spread of measles in Denmark was very 
similar in the two years described here. In both years, 
a single case resulted in a large cluster. In 2013, an 
additional small cluster of four cases was observed in 
a day-care centre, and even though no epidemiologi-
cal link could be established to the large cluster, the 
geographical and timely coincidence between the two 
clusters indicates that they could be a result of the 
same importation. If this is true, all cases in 2013 arose 
from just four importations, of which three were with-
out secondary cases. Our study demonstrates that the 
importation of measles virus only sometimes leads to 
a cluster, most likely if the virus is imported by children 
of pre-vaccination age.
The period in which new measles cases were detected 
was more prolonged in 2014 and included 10 more 
cases than in 2013. This may be a result of the slightly 
different importation pattern observed during 2014, 
where at least eight independent importations were 
detected. Of these, one resulted in the large cluster of 
eight cases and five cases resulted in one or two sec-
ondary cases (Table).
The 2014 cluster shares many similarities with earlier 
reported outbreaks in Denmark during 2008 and 2009, 
which were believed to have started in GPs’ waiting 
rooms [19,20]. This emphasises the need to rethink how 
to assemble potentially contagious people waiting to be 
examined and their relatives in small rooms – not only 
in hospital settings but throughout the entire health-
care system. In Denmark, there is pre-screening before 
patients are referred to the hospital emergency room, 
either by the GP or by telephone interview by specially 
trained nurses outside of GP opening hours. If patients 
with symptoms of contagious diseases are referred to 
an isolation waiting room at this stage, situations like 
that in 2014 may be prevented. Another lesson to be 
learned from the 2014 outbreak is that when trying to 
reach traced contacts who may have been exposed 
to the pathogen (e.g. measles virus in this instance), 
using postal mail services may not be the most appro-
priate approach. In this digitalised era, other methods, 
such as a bulk text message, could have been consid-
ered, since most people own and carry a mobile phone 
and text messages are independent of people being 
able to answer the phone at a specific time.
The phylogenetic analysis in our study showed that 
despite the fact that multiple importations occurred 
from different countries, the measles viruses detected 
were very closely related. This may be a result of very 
low mutation rates found in the genome of measles 
virus [21]. An interesting finding was that in 2014, mea-
sles virus sequences obtained from different specimens 
collected from the same patient showed conserved 
sequence differences in several cases. Of the seven 
cases infected with virus containing the mutation, five 
(2014-01 to 2014-04 and 2014-16) were epidemiologi-
cally connected to the large cluster (Figure 2), which 
supports the theory of simultaneous transfer of the two 
variants. This strongly indicates that different measles 
variants can co-exist and co-transfer simultaneously. 
How widespread this phenomenon is, is unknown 
since the MeaNS database only allows the uploading 
of one sequence per sample and does not allow the 
submission of ambiguous sequences. Furthermore, the 
result of Sanger sequencing is a consensus sequence: 
thus minority variants below the level of detection 
by Sanger sequencing (commonly estimated to be 
around 20%) are not reported. This finding could have 
important implications for the use of molecular data 
in cluster definitions. Cases might be discarded as 
not being epidemiologically linked if sequencing was 
only performed on one specimen. Deep sequencing 
using next-generation sequencing technology could be 
used to further elucidate the prevalence of co-existing 
sequence variants, and to epidemiologically link the 
transmission of such variants.
Our data from 2013 and 2014 clearly show that the vac-
cination coverage of the MMR vaccine in Denmark (in 
2013, it was 87% and 80% for the first and the second 
vaccination dose, respectively) is not high enough to 
prevent importation of measles leading to an outbreak 
due to insufficient herd protection or immunity. The 
data also indicate that the age of the index patient is 
important, if a single case is to result in an outbreak. 
In both years, the cluster index cases were children 
who had contact with many other children of the same 
age. Especially in 2014, very young children, 12 months 
of age or younger, led to the establishment of the out-
breaks. It has been argued that earlier administration 
of the first dose of MMR vaccine would lessen the risk 
of this type of outbreak [22]. A previous study has 
shown that vaccine failure after the second dose is sig-
nificantly higher if the first dose is given to children of 
naturally infected mothers at ≤ 15 months of age [23]. 
However, another study has shown that this may not be 
relevant in a population with a high vaccination cover-
age, since maternal antibodies from vaccinated moth-
ers wane much faster than those from naturally infected 
mothers. Thus, infants are only covered for around 
three months by maternal antibodies from vaccinated 
mothers [24]. Our results show that the second vaccina-
tion dose is important for sustained protection against 
infection, since at least seven cases were patients of an 
age at which the second MMR dose should have been 
administered. During the two years, seven persons 
contracted measles after having received only the first 
MMR vaccine dose. This corresponds with other find-
ings that receiving the second dose is more important 
than the interval between the two doses [25,26]. Even 
if the two-dose vaccination programme is adhered to, 
vaccine failure can be observed. In the present study, 
with the reservations mentioned in the results section, 
two cases (in their 20s and 30s) had received both 
MMR doses before infection. The probability of finding 
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cases among vaccinated individuals will increase with 
increasing vaccination coverage and others have also 
shown vaccine failure and even further transmission 
from persons with documented two-dose vaccinations 
[27]. Both cases in our study who had received both 
vaccination doses (2014-10 and 2014-11) were second-
ary cases and did not result in further transmission. 
Studies have shown that in areas with no endemic 
measles virus circulation, antibody titres will decline 
over time [28]. This might be one explanation for the 
occurrence of measles in two-dose vaccinated cases in 
our study. On the other hand, caution is needed when 
vaccination status is based on the memory of the indi-
viduals concerned. 
The effect of a third dose of MMR vaccine given at the 
age of 11 to 17 years has so far only been evaluated 
for mumps, but with promising results [29]. Whether 
this is also true for measles needs to be investigated. 
Regardless, the two-dose vaccination programme has, 
from its onset in Denmark in 1987, had an enormous 
effect on the incidence of measles. Until 1987, between 
20,000 and 70,000 cases per year were not uncom-
mon, and the mean number of measles-related deaths 
were one per 300 cases from 1877 to 1986 [16]. The last 
recorded death in Denmark caused by measles was in 
1989 [16].
Of the 44 cases during 2013 to 2014, only seven were 
of a pre-vaccination age, whereas 27 were unvacci-
nated. Seven cases received only the first dose but 
not the second. This shows that follow-up regarding 
missed vaccination, e.g. in the form of reminder let-
ters, may be necessary in order to ensure sufficient 
vaccination coverage. If the WHO goal of elimination 
of the disease by the end of 2015 is to be achieved, 
new measures are needed to ensure sufficient vacci-
nation coverage. These could include closer contact 
between parents and health authorities and clearer 
communication about vaccination, including risk–ben-
efit and responsibility aspects. In Denmark, interviews 
of parents showed that the most common reason for 
failure to vaccinate is forgetfulness [7]. Initial experi-
ence in Denmark with reminder letters to parents of 
children not registered with one or more vaccinations 
and updated information to parents reluctant to let 
their children be vaccinated against MMR shows prom-
ising results [30].
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